MK-677 vs HGH
MK-677 and HGH are referenced in performance and hormone optimisation contexts. Compare clinic governance, prescribing standards, and monitoring.
Both appear in performance-oriented listings, but HGH is tightly regulated while MK-677 is often framed as a secretagogue. Use this comparison to evaluate clinic oversight and eligibility criteria.
MK-677
A growth hormone secretagogue referenced in performance and longevity listings.
Potential benefits
- Often listed in performance clinics.
- Common in longevity protocols.
Considerations
- Regulatory status varies by jurisdiction.
- Requires clinician-led assessment.
Best for: Comparing performance clinics with secretagogue pathways.
HGH
Human growth hormone referenced in specialist hormone optimisation contexts with strict prescribing controls.
Potential benefits
- Sometimes listed in specialist hormone programmes.
- Typically requires tight monitoring.
Considerations
- Highly regulated with strict eligibility criteria.
- Requires specialist oversight.
Best for: Evaluating specialist hormone optimisation providers.
| Category | MK-677 | HGH |
|---|---|---|
| Directory context | Recovery / performance-focused listing context. | Weight / metabolic or longevity listing context. |
| Common goals | Recovery support, injury pathways, performance. | Weight management, metabolic health, longevity programs. |
| Guidance note | Informational listing only; suitability requires clinician review. | Informational listing only; suitability requires clinician review. |
Related clinics
No tagged clinics yet for this comparison pair.
Conclusion
These are not interchangeable and are governed by different prescribing models. Provider governance and eligibility criteria should drive the decision.